malondialdehyde has been researched along with Hyperlipoproteinemia Type II in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (19.05) | 18.7374 |
1990's | 4 (19.05) | 18.2507 |
2000's | 6 (28.57) | 29.6817 |
2010's | 5 (23.81) | 24.3611 |
2020's | 2 (9.52) | 2.80 |
Authors | Studies |
---|---|
Borja, MS; Davies, SS; Huang, J; Kon, V; Linton, MF; Smith, LE; Tao, H; Yancey, PG | 1 |
Amarnath, V; Blakemore, JL; Boutaud, O; Davies, SS; Ding, L; Huang, J; Linton, MF; Oates, JA; Roberts, LJ; Tao, H; Yancey, PG; Ye, F; Yermalitsky, V; Zagol-Ikapitte, I; Zhang, Y | 1 |
Hamzan, NS; Ibrahim, ZO; Mokhsin, A; Nawawi, H; Rahman, T; Rahmat, R; Razali, R; Thevarajah, M | 1 |
Ascaso, JF; Carmena, R; Chaves, FJ; Domenech, E; García-García, AB; Martínez-Hervás, S; Pallardó, FV; Real, JT; Redon, J; Sáez-Tormo, G; Tormos, MC | 1 |
Gökalp, D; Kizil, G; Kizil, M; Pirinccioglu, AG; Pirinccioglu, M | 1 |
Blesa, S; Carmena, R; Chaves, FJ; Gonzalez-Albert, V; Mansego, ML; Martinez, F; Martinez-Hervas, S; Real, JT; Redon, J; Saez, GT | 1 |
Ascaso, JF; Carmena, R; Chaves, FJ; García-García, AB; Martinez-Hervas, S; Pedro, T; Real, JT; Saez-Tormo, G; Tormo, C | 1 |
Baldi, S; Blandizzi, C; Del Tacca, M; L'Abbate, A; Lubrano, V; Natali, A; Palombo, C; Vassalle, C | 1 |
KiSakol, G; Kurtoglu, E; Sait Gonen, M; Ugur, A | 1 |
Bancells, C; Benítez, S; González-Sastre, F; Jorba, O; Ordóñez-Llanos, J; Sánchez-Quesada, JL; Villegas, V | 1 |
Kastelein, JJ; Miller, ER; Ridker, PM; Rodenburg, J; Tsimikas, S; Vissers, MN; Wiegman, A; Witztum, JL | 1 |
Brox, JH; Holme, S; Killie, JE; Lenner, RA; Nordøy, A | 1 |
Baker, SG; Birnbaum, M; Bradlow, BA; Chetty, N; Seftel, HC | 1 |
Colli, S; Maderna, P; Morazzoni, G; Sirtori, CR; Sirtori, M; Tremoli, E | 1 |
Ambrosio, G; Carbone, V; Chiariello, M; Condorelli, M; Corso, G; Malorni, A; Montefusco, S; Napoli, C; Palumbo, G; Postiglione, A; Ruocco, A; Triggiani, M | 1 |
Ambrosio, G; Calí, A; Chiariello, M; Corso, G; D'Armiento, FP; Formisano, S; Malorni, A; Mancini, FP; Napoli, C; Palumbo, G; Ruocco, A; Scarpato, N | 1 |
Gaszo, A; Granegger, S; Pirich, C; Sinzinger, H | 1 |
Furuhashi, K; Katsube, S; Kitano, S; Kobayashi, J; Maruyama, T; Masuda, M; Shimoda, M; Shinomiya, M | 1 |
Finckh, B; Klein, M; Kohlschütter, A; Ullrich, K; Wittenstein, B | 1 |
Calì, A; Colasanti, P; D'Armiento, FP; Di Gregorio, F; Napoli, C; Posca, T | 1 |
Avogaro, P; Bittolo Bon, G; Cazzolato, G | 1 |
4 trial(s) available for malondialdehyde and Hyperlipoproteinemia Type II
Article | Year |
---|---|
Oxidative stress and antioxidant enzyme values in lymphomonocytes after an oral unsaturated fat load test in familial hypercholesterolemic subjects.
Topics: Adolescent; Adult; Aged; Antioxidants; Fats, Unsaturated; Female; Glutathione; Glutathione Disulfide; Humans; Hyperlipoproteinemia Type II; Lymphocytes; Male; Malondialdehyde; Middle Aged; Monocytes; Oxidative Stress; Postprandial Period | 2013 |
Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
Topics: Anticholesteremic Agents; Antigen-Antibody Complex; Apolipoproteins B; Autoantibodies; Child; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Immunoglobulin G; Immunoglobulin M; Lipoproteins, LDL; Male; Malondialdehyde; Pravastatin; Siblings | 2006 |
Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients.
Topics: Blood Platelets; Cell Survival; Combined Modality Therapy; Diet; Diet Records; Diet, Fat-Restricted; Double-Blind Method; Eicosapentaenoic Acid; Epoprostenol; Fatty Acids, Essential; Fatty Acids, Unsaturated; Female; Fish Oils; gamma-Linolenic Acid; Humans; Hyperlipoproteinemia Type II; Linoleic Acid; Linoleic Acids; Lipid Peroxidation; Lipoproteins; Male; Malondialdehyde; Oenothera biennis; Plant Oils; Platelet Activation; Thromboxane B2 | 1999 |
Single LDL apheresis improves serum remnant-like particle-cholesterol, C-reactive protein, and malondialdehyde-modified-low-density lipoprotein concentrations in Japanese hypercholesterolemic subjects.
Topics: Apolipoproteins; Blood Component Removal; Body Mass Index; C-Reactive Protein; Cholesterol; Female; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Japan; Lipoproteins; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Triglycerides | 2002 |
17 other study(ies) available for malondialdehyde and Hyperlipoproteinemia Type II
Article | Year |
---|---|
Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Restores PON1 Activity.
Topics: Animals; Anti-Inflammatory Agents; Apolipoprotein A-I; Aryldialkylphosphatase; ATP Binding Cassette Transporter 1; Benzylamines; Disease Models, Animal; Free Radical Scavengers; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Macrophages; Malondialdehyde; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Peroxidase; Pyridoxine | 2020 |
Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Benzylamines; Cholesterol; Female; Humans; Hyperlipoproteinemia Type II; Inflammation; Lipid Peroxidation; Lipoproteins, HDL; Lipoproteins, IDL; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Receptors, LDL | 2020 |
Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.
Topics: Adult; Biomarkers; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; E-Selectin; Endothelium, Vascular; F2-Isoprostanes; Family; Fasting; Female; Humans; Hyperlipoproteinemia Type II; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Logistic Models; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Risk Factors; Triglycerides | 2017 |
Increased oxidative stress levels and normal antioxidant enzyme activity in circulating mononuclear cells from patients of familial hypercholesterolemia.
Topics: Adult; Antioxidants; Atherosclerosis; Catalase; Female; Glutathione; Glutathione Disulfide; Glutathione Peroxidase; Humans; Hyperlipoproteinemia Type II; Leukocytes, Mononuclear; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Superoxide Dismutase; Xanthine Oxidase | 2010 |
Malondialdehyde (MDA) and protein carbonyl (PCO) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemia.
Topics: Adolescent; Adult; Biomarkers; Case-Control Studies; Child; Female; Humans; Hyperlipoproteinemia Type II; Male; Malondialdehyde; Oxidative Stress; Protein Carbonylation; Young Adult | 2010 |
Different impacts of cardiovascular risk factors on oxidative stress.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Biomarkers; Cardiovascular Diseases; Catalase; Deoxyguanosine; Female; Gene Expression Profiling; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Synthase; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Hypertension; Male; Malondialdehyde; Middle Aged; NADPH Oxidases; Oxidative Stress; Phosphoproteins; Risk Factors; Superoxide Dismutase | 2011 |
The effect of lipoproteins on endothelial nitric oxide synthase is modulated by lipoperoxides.
Topics: Adult; Anticholesteremic Agents; Ascorbic Acid; Atorvastatin; Cells, Cultured; Cholesterol, LDL; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Lipid Peroxidation; Lipid Peroxides; Lipids; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Nitrates; Nitric Oxide Synthase; Nitrites; Pyrroles | 2003 |
Effect of lipoprotein apheresis on oxidative stress and antioxidant status in familial hypercholesterolemic patients.
Topics: Adult; Blood Component Removal; Catalase; Female; Glutathione Peroxidase; Humans; Hyperlipoproteinemia Type II; Lipid Peroxidation; Lipoproteins, LDL; Malondialdehyde; Oxidative Stress; Superoxide Dismutase | 2003 |
Impaired binding affinity of electronegative low-density lipoprotein (LDL) to the LDL receptor is related to nonesterified fatty acids and lysophosphatidylcholine content.
Topics: Antioxidants; Apolipoproteins B; Cells, Cultured; Cholesterol Esters; Fatty Acids, Nonesterified; Fibroblasts; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Lysophosphatidylcholines; Malondialdehyde; Phospholipases A; Protein Structure, Secondary; Protein Structure, Tertiary; Receptors, LDL | 2004 |
Platelets and coagulation in patients with familial hypercholesterolemia (type IIa).
Topics: Adult; Beta-Globulins; Bleeding Time; Blood Coagulation; Collagen; Epoprostenol; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Malondialdehyde; Middle Aged; Platelet Aggregation; Thrombin; Thromboxane B2 | 1983 |
Platelet function in familial hypercholesterolaemia in South Africa and the effects of probucol.
Topics: Adolescent; Adult; Aged; beta-Thromboglobulin; Child; Cholesterol; Coronary Disease; Female; Humans; Hyperlipoproteinemia Type II; Male; Malondialdehyde; Middle Aged; Phenols; Platelet Aggregation; Probucol; South Africa | 1982 |
Increased platelet sensitivity and thromboxane B2 formation in type-II hyperlipoproteinaemic patients.
Topics: Adolescent; Adult; Aged; Arachidonic Acids; Blood Platelets; Cholesterol; Collagen; Female; Humans; Hyperlipoproteinemia Type II; In Vitro Techniques; Male; Malondialdehyde; Middle Aged; Platelet Aggregation; Thromboxane B2; Thromboxanes | 1984 |
Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
Topics: Apolipoprotein B-100; Apolipoproteins B; Cholesterol Esters; Chromatography, Thin Layer; Fatty Acids; Gas Chromatography-Mass Spectrometry; Homozygote; Humans; Hyperlipoproteinemia Type II; Lipid Peroxidation; Lipoproteins, LDL; Malondialdehyde; Membrane Proteins; Oxidation-Reduction; Reactive Oxygen Species; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class B; Vitamin E; Xanthine Oxidase | 1995 |
Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia.
Topics: Apolipoprotein B-100; Apolipoproteins B; Blood Component Removal; Cholesterol Esters; Free Radicals; Gas Chromatography-Mass Spectrometry; Homozygote; Humans; Hyperlipoproteinemia Type II; Lipid Peroxidation; Lipoproteins, LDL; Malondialdehyde; Oxidation-Reduction; Phospholipids; Triglycerides | 1997 |
Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia.
Topics: Adolescent; Adult; Antioxidants; Ascorbic Acid; Child; Child, Preschool; Cholesterol; Chromatography, High Pressure Liquid; Coenzymes; Diabetes Mellitus, Type 1; Female; Glycogen Storage Disease Type I; Hemoglobins; Homocysteine; Humans; Hyperlipoproteinemia Type II; Infant; Lipoproteins, LDL; Male; Malondialdehyde; Sulfhydryl Compounds; Triglycerides; Ubiquinone; Uric Acid; Vitamin E | 2002 |
[Clinico-pathological evaluation of patients with homozygous familial hypercholesterolemia].
Topics: Adult; Apolipoproteins B; Apolipoproteins E; Cholesterol, LDL; Echocardiography; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Malondialdehyde; Receptors, LDL | 1991 |
Meaning of a modified LDL in humans.
Topics: Apolipoprotein B-100; Apolipoproteins B; Arteriosclerosis; Cholesterol Esters; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Malondialdehyde; Molecular Weight; Platelet Aggregation; Receptors, LDL | 1987 |